Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.37
- Piotroski Score 5.00
- Grade Buy
- Symbol (MET)
- Company MetLife, Inc.
- Price $82.50
- Changes Percentage (1.18%)
- Change $0.96
- Day Low $81.79
- Day High $82.99
- Year High $82.99
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
- Last Earnings 07/09/2024
- Ex-Dividend for 5/16 Dividend 08/06/2024
- Dividend Payable 09/10/2024
- Today N/A
- Next Earnings (Estimated) 10/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $80.00
- High Stock Price Target $145.00
- Low Stock Price Target $74.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.89
- Trailing P/E Ratio 24.24
- Forward P/E Ratio 24.24
- P/E Growth 24.24
- Net Income $1.58 B
Income Statement
Quarterly
Annual
Latest News of MET
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Mets to start David Peterson in crucial Sunday game vs. Brewers
The struggling Mets will rely on David Peterson to pitch in the series finale against the Brewers. Despite recent team setbacks, Manager Carlos Mendoza trusts Peterson's abilities to help secure a wil...
By New York Post | 5 hours ago -
Comet A3 Tracker For The Week Ahead -- Where And When To See It
Comet A3, also known as Comet Tsuchinshan-ATLAS (C/2023 A3), is visible in the east before sunrise this week in the Northern Hemisphere. To catch a glimpse, rise early before it's obscured by dawn....
By Forbes | 5 hours ago -
Buffalo Bills at Baltimore Ravens odds, expert picks, how to watch: Josh Allen vs. Lamar Jackson in primetime
Josh Allen has proven his ability to excel without star receiver Stefon Diggs, leading the Buffalo Bills to a 3-0 start....
By The New York Times | 5 hours ago
